Literature DB >> 26630938

Clinicopathologic Differences in Patients with Gallbladder Cancer According to the Presence of Anomalous Biliopancreatic Junction.

Jihoon Chang1, Jin-Young Jang1, Mee Joo Kang1, Woohyun Jung1, Yong Chan Shin1, Sun-Whe Kim2.   

Abstract

BACKGROUND: Anomalous biliopancreatic junction (ABPJ) is a risk factor for gallbladder cancer (GBC). This study investigated the significance of ABPJ in patients with GBC.
METHODS: Of the 453 patients with GBC underwent surgery at Seoul National University Hospital between 2000 and 2014, the 401 patients who can be assessed for the presence of ABPJ with radiologic image were analyzed.
RESULTS: The 401 patients with GBC included 183 (45.6 %) males and 218 (54.4 %) females. ABPJ was identified in 69 (17.2 %) patients, 22 (31.9 %) males and 47 (68.1 %) females. Choledochal cyst (CC) was identified in 18 (4.5 %) patients, all of whom had ABPJ. Curative surgery was accomplished in 68.1 %. A comparison of patients with and without ABPJ showed that mean age (59.9 vs. 65.1 years, p < 0.001) and association with gallbladder stone (8.7 vs. 24.7 %, p = 0.002) were significantly lower in the ABPJ group, while the proportion of female (68.1 vs. 51.5 %, p = 0.012), bile duct resection rate (47.8 vs. 18.4 %, p < 0.001), and curative resection rate (81.1 vs. 65.7 %, p = 0.003) were significantly higher in the ABPJ group. Overall 5-year survival rates were similar in the ABPJ and non-ABPJ groups (74.4 vs. 69.0 %, p = 0.533). In patients with ABPJ, the presence of CC did not have a significant effect on survival (p = 0.099).
CONCLUSIONS: ABPJ was found in 17.2 % of patients with GBC. ABPJ is associated with younger age, female gender, absence of gallbladder stones, higher BDR rate, and higher curative resection rate. However, neither ABPJ nor CC was prognostic of survival in curatively treated patients with GBC.

Entities:  

Mesh:

Year:  2016        PMID: 26630938     DOI: 10.1007/s00268-015-3359-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  28 in total

Review 1.  Japanese clinical practice guidelines for pancreaticobiliary maljunction.

Authors:  Terumi Kamisawa; Hisami Ando; Masafumi Suyama; Mitsuo Shimada; Yuji Morine; Hiroshi Shimada
Journal:  J Gastroenterol       Date:  2012-06-22       Impact factor: 7.527

2.  Long-term results of treatment for pancreaticobiliary maljunction without bile duct dilatation.

Authors:  Jiro Ohuchida; Kazuo Chijiiwa; Masahide Hiyoshi; Kiichiro Kobayashi; Hiroyuki Konomi; Masao Tanaka
Journal:  Arch Surg       Date:  2006-11

3.  Choledochal cyst and associated malignant tumors in adults: a multicenter survey in South Korea.

Authors:  Seung Eun Lee; Jin-Young Jang; Young-Joo Lee; Dong Wook Choi; Woo Jung Lee; Baik-Hwan Cho; Sun-Whe Kim
Journal:  Arch Surg       Date:  2011-10

Review 4.  [Nation wide survey of pancreaticobiliary maljunction].

Authors:  Yuji Morine; Mitsuo Shimada; Hiroki Ishibashi
Journal:  Nihon Shokakibyo Gakkai Zasshi       Date:  2014-04

5.  Proteomic-based analysis for identification of potential serum biomarkers in gallbladder cancer.

Authors:  Yi Tan; Shi-Yin Ma; Fu-Qiang Wang; Hai-Ping Meng; Cuizhu Mei; Angen Liu; Hao-Rong Wu
Journal:  Oncol Rep       Date:  2011-06-17       Impact factor: 3.906

6.  Endoscopic retrograde cholangiopancreatography in the evaluation of anomalous junction of the pancreaticobiliary duct and related disorders.

Authors:  B Nagi; R Kochhar; D Bhasin; K Singh
Journal:  Abdom Imaging       Date:  2003 Nov-Dec

7.  K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction.

Authors:  Toshiki Matsubara; Yoichi Sakurai; Li-Zhu Zhi; Hirotake Miura; Masahiro Ochiai; Takahiko Funabiki
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

8.  Secretin-stimulating MRCP in patients with pancreatobiliary maljunction and occult pancreatobiliary reflux: direct demonstration of pancreatobiliary reflux.

Authors:  Utaroh Motosugi; Tomoaki Ichikawa; Tsutomu Araki; Fumiaki Kitahara; Tadashi Sato; Jun Itakura; Hideki Fujii
Journal:  Eur Radiol       Date:  2007-04-20       Impact factor: 5.315

9.  Diagnostic criteria for pancreaticobiliary maljunction 2013.

Authors:  Terumi Kamisawa; Hisami Ando; Yoshinori Hamada; Hideki Fujii; Tsugumichi Koshinaga; Naoto Urushihara; Takao Itoi; Hiroshi Shimada
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-12-05       Impact factor: 7.027

10.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

View more
  5 in total

1.  T2 gallbladder cancer shows substantial survival variation between continents and this is not due to histopathologic criteria or pathologic sampling differences.

Authors:  Mia S DeSimone; Michael Goodman; Burcin Pehlivanoglu; Bahar Memis; Serdar Balci; Juan Carlos Roa; Kee-Taek Jang; Jin-Young Jang; Seung-Mo Hong; Kyoungbun Lee; Haeryoung Kim; Hye-Jeong Choi; Takashi Muraki; Juan Carlos Araya; Enrique Bellolio; Juan M Sarmiento; Shishir K Maithel; Hector F Losada; Olca Basturk; Michelle D Reid; Jill Koshiol; Volkan Adsay
Journal:  Virchows Arch       Date:  2021-01-07       Impact factor: 4.064

2.  Pancreatobiliary Maljunction-associated Gallbladder Cancer Is as Common in the West, Shows Distinct Clinicopathologic Characteristics and Offers an Invaluable Model for Anatomy-induced Reflux-associated Physio-chemical Carcinogenesis.

Authors:  Takashi Muraki; Burcin Pehlivanoglu; Bahar Memis; Michelle D Reid; Takeshi Uehara; Olca Basturk; Jennifer Golia Pernicka; David S Klimstra; William R Jarnagin; Tetsuya Ito; Osamu Hasebe; Shinji Okaniwa; Naoto Horigome; Takeshi Hisa; Pardeep Mittal; Juan M Sarmiento; Shishir K Maithel; Jill Koshiol; Susan Tsai; Douglas Evans; Mert Erkan; Volkan Adsay
Journal:  Ann Surg       Date:  2020-11-12       Impact factor: 13.787

3.  Surgical Outcomes for Perihilar Cholangiocarcinoma with Vascular Invasion.

Authors:  Ryota Higuchi; Takehisa Yazawa; Shuichiro Uemura; Wataru Izumo; Takehiro Ota; Kosuke Kiyohara; Toru Furukawa; Hiroto Egawa; Masakazu Yamamoto
Journal:  J Gastrointest Surg       Date:  2018-09-10       Impact factor: 3.452

Review 4.  A narrative review of gallbladder adenomyomatosis: what we need to know.

Authors:  Kit-Fai Lee; Esther H Y Hung; Howard H W Leung; Paul B S Lai
Journal:  Ann Transl Med       Date:  2020-12

5.  Clinical characteristics of patients with malignancy and long-term outcomes of surgical treatment of patients with choledochal cyst.

Authors:  Wung Sun Han; Hongbeom Kim; Hee Ju Sohn; Mirang Lee; Yoon Hyung Kang; Hyeong Seok Kim; Youngmin Han; Jae-Seung Kang; Wooil Kwon; Jin-Young Jang
Journal:  Ann Surg Treat Res       Date:  2021-12-01       Impact factor: 1.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.